Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow SUPERNUS PHARMACEUTICALS, INC.

Get SEC filing alerts via email and in your feed for SUPERNUS PHARMACEUTICALS, INC.

SUPN

SUPERNUS PHARMACEUTICALS, INC.

Latest news & discussion for SUPERNUS PHARMACEUTICALS, INC.:

1
1
SUPERNUS PHARMACEUTICALS, INC. Supernus Pharmaceuticals Reports $149.8 Million Revenue in Q1 2025, Net Loss of $11.8 Million

Via official filing (AI summary) | 19 days ago | 0 comments

2
1
SUPERNUS PHARMACEUTICALS, INC. Supernus Pharmaceuticals Reports 14% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments